Impact of diabetes on the effects of SGLT2 inhibitors on kidney outcomes: An updated drug/dose-dependent meta-analysis
Clinical Nephrology · 01.02.2026 · 105 (2) · 128-149
DOI: 10.5414/cn111749 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Clinical Nephrology, erschienen am 01.02.2026. Verfasst von Jingfeng Qian und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Renal Insufficiency, Chronic, Kidney, Diabetic Nephropathies.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Qian, J., & Xu, Y. (2026). Impact of diabetes on the effects of SGLT2 inhibitors on kidney outcomes: An updated drug/dose-dependent meta-analysis. Clinical Nephrology, 105(2), 128-149. https://doi.org/10.5414/cn111749
Vancouver
Qian J, Xu Y. Impact of diabetes on the effects of SGLT2 inhibitors on kidney outcomes: An updated drug/dose-dependent meta-analysis. Clinical Nephrology. 2026;105(2):128-149. doi:10.5414/cn111749
BibTeX
@article{Qian2026,
author = {Qian, Jingfeng and Xu, Yanqiu},
title = {Impact of diabetes on the effects of SGLT2 inhibitors on kidney outcomes: An updated drug/dose-dependent meta-analysis},
journal = {Clinical Nephrology},
year = {2026},
volume = {105},
number = {2},
pages = {128--149},
doi = {10.5414/cn111749}
}
EUVIMED